HomeHealth CareDrugs

Drugs

Health Care

Latigo Nets $346 Million from Public Offering

Howard Fine - August 17, 2026

Health Care

Amgen Drug Reviewed Amid Deaths

Howard Fine - May 25, 2026

Health Care

Atara Bounces Back with FDA

Howard Fine - May 18, 2026

Health Care

Amgen Sees C-Suite Shifts

Howard Fine - May 4, 2026

Health Care

New Sign-Off Propels ImmunityBio

Howard Fine - February 9, 2026

Health Care

ImmunityBio, Xencor Drugs Win E.U. Nods

Howard Fine - January 12, 2026

Health Care

Amgen Buys U.K. Biotech Company

Howard Fine - January 12, 2026

Health Care

Arrowhead Hits the Mark

Howard Fine - December 8, 2025

Health Care

City of Hope Dives Into Drug Trials

Howard Fine - September 15, 2025

Health Care

Biotech Giant Amgen Will Expand Its R&D

Howard Fine - September 15, 2025

Health Care

Arrowhead, Novartis Ink Agreement

Howard Fine - September 15, 2025

Health Care

Atara Makes Second Try With FDA

Howard Fine - August 18, 2025

Health Care

ImmunityBio Wins U.K. Approval

Howard Fine - August 18, 2025

Health Care

Arrowhead Shares Bumpy After Partner Troubles

Howard Fine - July 28, 2025

Health Care

GoodRx Has New Service For ED Meds

Howard Fine - June 23, 2025

Health Care

Anktiva Approved For Additional Treatment

Howard Fine - June 23, 2025

Health Care

FDA Delivers Blow to ImmunityBio

Howard Fine - May 19, 2025

Health Care

NeOnc Sees Share Price Fall Since Going Public

Mark R. Madler - April 14, 2025

Health Care

Acelyrin Sees Stock Price Rise Amid Rights Plan

Mark R. Madler - March 24, 2025

Health Care

ImmunityBio Seeks Drug Approvals

Howard Fine - February 24, 2025

Health Care

Atara Biotherapeutics Sees Its Share Price Fall

Mark R. Madler - January 27, 2025

Health Care

Avita Gets FDA Nod For Device

Howard Fine - January 27, 2025

Health Care

GoodRx Adds Pet Program

Howard Fine - January 27, 2025

Health Care

Amgen Plans To Expand N.C. Campus

Howard Fine - December 30, 2024

Drugs

Latigo Nets $346 Million from Public Offering

Amgen Drug Reviewed Amid Deaths

Atara Bounces Back with FDA

Amgen Sees C-Suite Shifts

New Sign-Off Propels ImmunityBio

ImmunityBio, Xencor Drugs Win E.U. Nods

Amgen Buys U.K. Biotech Company

Arrowhead Hits the Mark

City of Hope Dives Into Drug Trials

Biotech Giant Amgen Will Expand Its R&D

Arrowhead, Novartis Ink Agreement

Atara Makes Second Try With FDA

ImmunityBio Wins U.K. Approval

Arrowhead Shares Bumpy After Partner Troubles

GoodRx Has New Service For ED Meds

Anktiva Approved For Additional Treatment

FDA Delivers Blow to ImmunityBio

NeOnc Sees Share Price Fall Since Going Public

Acelyrin Sees Stock Price Rise Amid Rights Plan

ImmunityBio Seeks Drug Approvals

Atara Biotherapeutics Sees Its Share Price Fall

Avita Gets FDA Nod For Device

GoodRx Adds Pet Program

Amgen Plans To Expand N.C. Campus

Advertise with Us

About Us

Membership Center

Other Journals